mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.02 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.02 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.02 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.02 |
mRNA |
SB 216763 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.02 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.02 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.14 |
0.02 |
mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
-0.097 |
0.02 |